Novel Reactions of Electrophilic Nitrogen for Preparing Bioactive Molecules

亲电氮制备生物活性分子的新反应

• 批准号: 10416714
• 负责人: Donald Allen Watson
• 金额: $ 36.26万
• 依托单位: UNIVERSITY OF DELAWARE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10416714
• 关键词: Alkylation; Amines; Automobile Driving; Biological; Catalysis; Chemical Structure; Chemicals; Chemistry; Complex; Coupling; Cyclization; Development; Dioxanes; Disease; Drug Compounding; Drug Kinetics; Felis catus; Follow-Up Studies; Health; Homo; Human; Letters; Ligands; Medical; Methods; Molecular; Narcotics; Natural Products; Nitrogen; Nitrogen Oxides; Organic Synthesis; Pharmacologic Substance; Phosphines; Positioning Attribute; Process; Publishing; Reaction; Research; Resistance; Route; Safety; Synthesis Chemistry; System; Technology; Time Study; Transition Elements; base; cancer cell; chemical reaction; design; drug structure; human disease; improved; inhibitor; innovation; innovative technologies; interest; nitroalkane; nitrogen compounds; novel; novel therapeutics; oxidation; programs; small molecule; stereochemistry; strictamine; tool; tumor necrosis factor-alpha inhibitor

Nitrogen-rich small molecules are critical to human health as they constitute the vast majority of all known pharmaceutical agents. As the requirements for new drugs become stricter, and as the diseases that are targeted become more complex, the chemical structures of those compounds are also becoming more complex. This is driving the need for more efficient means to prepare ever more complex nitrogen-containing small molecules. Typically, in synthetic chemistry, most chemical reactions of nitrogen centers involve low valent, nucleophilic nitrogen atoms. Over the past 100 years, countless synthetic transformations have been developed to prepare nitrogen-containing molecules using this paradigm. In contrast, this proposal seeks to leverage nitrogen compounds in higher oxidation states to seek new reactivity and chemical processes that can prepare complex nitrogen-containing molecules in new ways. Specifically, based upon a strong set of published preliminary results, we will develop new Heck-like reactions of electrophilic nitrogen centers as a means to construct highly substituted stereochemically and topologically complex nitrogen heterocycles. Our studies will discover new nitrogen electrophiles that can participate in these aza-Heck cyclizations, develop novel routes to important classes of biologically active heterocycles, design asymmetric entries into these compounds to control absolute stereochemistry, and dig deeper into the fundamental mechanisms of the reactions to enable further understanding of the processes. To demonstrate the importance of aza-Heck cyclizations, we will also prepare several highly complex natural products with interesting biological profiles in highly expedient ways. Each synthesis will feature aza-Heck technologies as the key enabling reaction. As reflected in our support letters, we are well positioned for follow-up studies at the completion of these synthetic efforts. We will also continue to develop new catalytic methods to prepare complex nitroalkanes and seek to use those compounds in novel transformation for preparing bioactive molecules. Overall, we expect that the development of this chemistry will positively impact human health by providing synthetic, medicinal, and process chemists valuable new tools for the construction of nitrogen-rich bioactive small molecules. At the same time, this study will provide fundamental advances in transition metal-catalyzed cross-coupling chemistry. Modified Specific Aims Nitrogen-rich small molecules are critical to human health as they constitute the vast majority of all known pharmaceutical agents. As targeted diseases are more complex and the requirements for new drugs become stricter to increase safety, the requirements and structures of the drug compounds have also become more complex. In particular, the need for increased selectivity and improved pharmacokinetics is driving a move away from traditional “flat” pharmaceuticals towards those that are chiral and rich in sp3 centers.1 In turn, this has driven the need to develop new methods that can efficiently prepare complex and highly substituted stereogenic nitrogen-containing small molecules. The proposed research will focus on new methods for preparing topologically complex, nitrogen-containing small molecules. We will focus on two strategies that are thematically related in the utilization of high-valent nitrogen precursors. These reactions are a departure from the vast majority of synthetic transformations that rely on low-valent nucleophilic nitrogen centers and will allow rapid access to compounds that traditional methods struggle to prepare. First, we will develop cyclizations of stable, readily prepared nitrogen electrophiles to prepare highly substituted stereogenic aza-heterocycles. These aza-Heck cyclizations will allow facile access to biologically and medicinally relevant heterocycles that other methods struggle to access. Second, we will develop new reactions of nitroalkanes to prepare complex amines. Specific Aims: Specific Aim 1: New Reactions of Electrophilic Nitrogen to Prepare Complex Heterocycles We will develop innovative Heck-type cyclizations of nitrogen electrophiles. This will include developing new routes to highly substituted nitrogen heterocycles of high biological importance, accessing larger heterocycles than are currently possible using aza-Heck reactions, developing asymmetric versions of these cyclizations, and studying the novel mechanisms of these transformations. This will allow rapid entry into heterocyclic systems and enable the synthesis of many bioactive compounds and natural products. Specific Aim 2: Synthesis of Complex, Biologically Active Molecules Using Aza-Heck Strategies We will apply aza-Heck cyclizations to the synthesis of complex natural products of direct interest to human disease. The proposed routes are extremely efficient and will demonstrate the power of aza-Heck technology over traditional synthetic methods. The synthetic efficiency, combined with the bioactivity of the chosen targets, will enable biological follow-up studies. Specific Aim 3: Nitroalkane Alkylation We will develop new reactions of nitroalkanes, including photodependent alkylations of highly substituted nitroalkanes, asymmetric nitroalkane alkylations, and asymmetric reductions of nitroalkanes, enabling innovative entries into biologically important alkyl amines. The unique and complex mechanisms of these transformations will also be elucidated. Overall, this research program will discover and seek to understand new methods for preparing complex, biomedically relevant compounds and enable the synthesis of target molecules of specific interest to the treatment of various human diseases.

富氮小分子对人类健康至关重要，因为它们构成了所有已知药物制剂的绝大多数。随着对新药的要求越来越严格，以及针对的疾病变得越来越复杂，这些化合物的化学结构也变得越来越复杂。这促使人们需要更有效的方法来制备更复杂的含氮小分子。